162 related articles for article (PubMed ID: 25127987)
1. Polymorphisms in immune mediators associate with risk of cervical cancer.
Zhang Z; Fye S; Borecki IB; Rader JS
Gynecol Oncol; 2014 Oct; 135(1):69-73. PubMed ID: 25127987
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.
Ma D; Hovey RL; Zhang Z; Fye S; Huettner PC; Borecki IB; Rader JS
Gynecol Oncol; 2013 Nov; 131(2):445-50. PubMed ID: 23927961
[TBL] [Abstract][Full Text] [Related]
3. Association of TNF-a (rs361525 and rs1800629) with susceptibility to cervical intraepithelial lesion and cervical carcinoma in women from Republic of North Macedonia.
Duvlis S; Dabeski D; Cvetkovski A; Mladenovska K; Plaseska-Karanfilska D
Int J Immunogenet; 2020 Dec; 47(6):522-528. PubMed ID: 32662227
[TBL] [Abstract][Full Text] [Related]
4. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
5. Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina).
Badano I; Stietz SM; Schurr TG; Picconi AM; Fekete D; Quintero IM; Cabrera MD; Campos RH; Liotta JD
J Clin Virol; 2012 Jan; 53(1):54-9. PubMed ID: 22019249
[TBL] [Abstract][Full Text] [Related]
6. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.
Shi TY; Zhu ML; He J; Wang MY; Li QX; Zhou XY; Sun MH; Shao ZM; Yu KD; Cheng X; Wu X; Wei Q
Hum Genet; 2013 Mar; 132(3):301-12. PubMed ID: 23180271
[TBL] [Abstract][Full Text] [Related]
8. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.
Ivansson EL; Juko-Pecirep I; Gyllensten UB
Gynecol Oncol; 2010 Mar; 116(3):544-8. PubMed ID: 19959217
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
[TBL] [Abstract][Full Text] [Related]
10. CD83 polymorphisms and cervical cancer risk.
Yu KJ; Rader JS; Borecki I; Zhang Z; Hildesheim A
Gynecol Oncol; 2009 Aug; 114(2):319-22. PubMed ID: 19446866
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variants and risk for HPV persistence and progression to cervical cancer.
Wang SS; Gonzalez P; Yu K; Porras C; Li Q; Safaeian M; Rodriguez AC; Sherman ME; Bratti C; Schiffman M; Wacholder S; Burk RD; Herrero R; Chanock SJ; Hildesheim A
PLoS One; 2010 Jan; 5(1):e8667. PubMed ID: 20084279
[TBL] [Abstract][Full Text] [Related]
13. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women.
Jiang J; Li N; Shen Y; Liu J; Liu L; Du J; Lei Y; Wen Y; Yang L; Guo L; Zhang K; Qiang F; Wang S; Hu Z; Dai M; Shen H
Gynecol Oncol; 2013 May; 129(2):401-5. PubMed ID: 23428460
[TBL] [Abstract][Full Text] [Related]
16. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
Jin Y; Qiu S; Shao N; Zheng J
Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
[TBL] [Abstract][Full Text] [Related]
17. Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach.
Abdulkadir M; Londono D; Gordon D; Fernandez TV; Brown LW; Cheon KA; Coffey BJ; Elzerman L; Fremer C; Fründt O; Garcia-Delgar B; Gilbert DL; Grice DE; Hedderly T; Heyman I; Hong HJ; Huyser C; Ibanez-Gomez L; Jakubovski E; Kim YK; Kim YS; Koh YJ; Kook S; Kuperman S; Leventhal B; Ludolph AG; Madruga-Garrido M; Maras A; Mir P; Morer A; Müller-Vahl K; Münchau A; Murphy TL; Plessen KJ; Roessner V; Shin EY; Song DH; Song J; Tübing J; van den Ban E; Visscher F; Wanderer S; Woods M; Zinner SH; King RA; Tischfield JA; Heiman GA; Hoekstra PJ; Dietrich A
Eur Arch Psychiatry Clin Neurosci; 2018 Apr; 268(3):301-316. PubMed ID: 28555406
[TBL] [Abstract][Full Text] [Related]
18. TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.
Barbisan G; Pérez LO; Contreras A; Golijow CD
Tumour Biol; 2012 Oct; 33(5):1549-56. PubMed ID: 22592655
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of proteasome subunit genes of the MHC-I antigen-presenting system are associated with cervical cancer in a Chinese Han population.
Li C; Dai S; Yan Z; Zhang X; Liu S; Wang X; Wang J; Shi L; Yao Y
Hum Immunol; 2020 Aug; 81(8):445-451. PubMed ID: 32684411
[TBL] [Abstract][Full Text] [Related]
20. First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer.
Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL
Gene; 2013 Jul; 524(2):208-13. PubMed ID: 23644138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
